We warmly invite you to this public symposium and Prof. DePinho’s lecture.
| Speaker: | Prof. Ronald A. DePinho, Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA |
| Title: | „Genetics and Biology of Pancreas Cancer, and its Cure“ |
| Introduction by Dr. Björn von Eyss | |
| Date: | May 27, 2024 at 5 pm |
| Place: | Seminar room „Nucleus“, FLI 1 Beutenbergstraße 11, Jena |
| Hosts: | Dr. Björn von Eyss, Prof. K. Lenhard Rudolph (FLI) & Prof. Andreas Hochhaus (UKJ) |
Life and Work
- Medical degree with distinction from Albert Einstein College of Medicine 1983
- Professor in 1988 at Albert Einstein College
- Tenured Professorship at Harvard Medical School / Dana-Farber Cancer Institute (1998–2011), founding director of the Belfer Institute for Applied Cancer Science
- since 2011 Professor of Tumor Biology at the University of Texas / MD Anderson Cancer Center, President from 2011 to 2017
- pioneered genetic mouse models to study cancer
- numerous fundamental discoveries on tumor biology (some with implication for aging or degenerative diseases)
- p53 acts as a tumor suppressor by activating apoptosis during faulty cell cycles
- identified in vivo role of INK4a/ARF is a genuine tumor suppressor
- connections of ARF with the p53 pathway and its role in protecting against environmental carcinogens
- telomere dysfunction as a cause of aging and carcinogenesis
- paved the way for the use of telomerase inhibitors as cancer drugs
- established tumor maintenance models
DePinho has an h-index of 188, is founder of various pharmaceutical companies, and will be included in Tek-Wan-Do Hall of Fame in summer 2024.
For further information on Prof. DePinho, please go to:
